Sign in to continue:

Sunday, March 29th, 2026

Author: Minichart

Cingulate Reports 2025 Financial Results, Advances CTx-1301 ADHD Drug with New Patents and NDA Progress

Cingulate Inc. Reports Q4 and Full Year 2025 Results: Key Hi...

GSI Technology Concludes Strategic Alternatives Review and Reaffirms Standalone Growth Strategy

GSI Technology Announces Conclusion of Strategic Alternative...

Marine Products Corporation Files 8-K with SEC Detailing Company Information and Compliance Disclosures

Marine Products Corporation Files Form 8-K: Key Developments...

ACNB Corporation 8-K Filing Details: Company Information, Address, and SEC Registration Data

ACNB Corporation Announces Grant of Variable Equity Awards t...